GalNAc Disialyl Lc4 (Hexasaccharide)

General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference

4 reference for EP0097

sort by year Reference detail
1 Ito A, Levery SB, Saito S, Satoh M, Hakomori S.
A novel ganglioside isolated from renal cell carcinoma.
J Biol Chem. 2001 May 18;276(20):16695-703
PMID: 11278988
2 Saito S, Egawa S, Endoh M, Ueno S, Ito A, Numahata K, Satoh M, Kuwao S, Baba S, Hakomori S, Arai Y.
RM2 antigen (beta1,4-GalNAc-disialyl-Lc4) as a new marker for prostate cancer.
Int J Cancer. 2005 May 20;115(1):105-13
PMID: 15704108
3 Ito A, Saito S, Masuko T, Oh-Eda M, Matsuura T, Satoh M, Nejad FM, Enomoto T, Orikasa S, Hakomori SI.
Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues.
Glycoconj J. 2001 Jun ;18(6):475-85
PMID: 12084983
4 Saito S, Levery SB, Salyan ME, Goldberg RI, Hakomori S.
Common tetrasaccharide epitope NeuAc alpha 2-->3Gal beta 1-->3(Neu-Ac alpha 2-->6)GalNAc, presented by different carrier glycosylceramides or O-linked peptides, is recognized by different antibodies and ligands having distinct specificities.
J Biol Chem. 1994 Feb 25;269(8):5644-52
PMID: 7509790